371470·Stock-Sector-Healthcare
TIGER CHINA BIOTECH SOLACTIVE
Introduction
The TIGER CHINA BIOTECH SOLACTIVE ETF seeks to provide investment results that, before expenses, correspond generally to the price and yield performance of the Solactive China Biotech Index(Net Total Return)
Investment Points
An ETF that invests in Chinese healthcare companies with future growth potential
Benchmark Index
Solactive China Biotech Index(Net Total Return)
Benchmark Index Description
An index that includes companies within the biotechnology theme of the Chinese healthcare industry, incorporating up to 30 Chinese biotechnology companies listed on the exchanges of China, Hong Kong, and the United States.
Issuer
Mirae Asset Global Investments Co.,Ltd.
Brand
TIGER
Total Fee
0.49
Listing Date
2020-12-08
International Securities Code
KR7371470006
Market Information
Market Capitalization
34,122,000,000KRW
Transaction Amount
269,839,345KRW
Trading Volume
45,153
Shares Outstanding
5,640,000
NAV
5,812
52-Week High
6,750KRW
52-Week Low
4,745KRW